New GLP-1 pill delivers up to 12% weight loss in 36 weeks
An experimental GLP-1 pill helped people with obesity or overweight lose as much as 12.1% of their body weight in just 36 weeks. Unlike injectable drugs such as Wegovy and Ozempic, aleniglipron is a small molecule that can be taken once daily with...
schedule
14:50 visibility
44 views
Source: Science Daily
An experimental GLP-1 pill helped people with obesity or overweight lose as much as 12.1% of their body weight in just 36 weeks. Unlike injectable drugs such as Wegovy and Ozempic, aleniglipron is a small molecule that can be taken once daily with or without food and could potentially be produced more easily at scale.
Kenya has recorded a second Ebola death, the health ministry said late Friday. The 65-year-old woman had developed symptoms during quarantine and was a close relative of a Kenyan man who died of the disease.
Hosted by TechCrunch in partnership with Fidelity Private Shares, the full-day event goes beyond fundraising and AI to explore the realities of finding customers, building teams, sharpening a pitch, developing founder leadership, and scaling...
Switzerland says patient is wife of Swiss diplomat and believed to have contracted virus while travelling in UgandaHealth officials across Africa are racing to determine how Nigeria’s first Ebola patient in more than a decade became infected, amid...
When we published our review of the iPhone Duo, I got a lot of hopeful questions from my fellow Mini fans who took note of the cover screen's Mini-ish 5.4-inch size. "Is this… a small phone that turns into a tablet?" they asked. And I'm sorry to be...
Jean-Emile Jammine is pleased to welcome Gökçe Tuncel, Sociologist and post-doctoral researcher associated with the Université Paris-Est Créteil (UPEC). For Tuncel, the wave of youth-led protests across France, Albania, India and Italy reveals more...
An admirably dark and wince-inducing detour for DC Studios, who get a lot right with 'Clayface' when it comes to horror. However, the script lets it down in the second half, leading to a bold but uneven result.
Euronews
We use cookies to improve your experience. By continuing to use this site, you agree to our use of cookies. Learn more